InfuSystem Holdings, Inc. (INFU)
- Previous Close
8.01 - Open
7.94 - Bid 6.88 x 2200
- Ask 7.91 x 2900
- Day's Range
7.78 - 7.97 - 52 Week Range
7.70 - 11.44 - Volume
17,828 - Avg. Volume
45,540 - Market Cap (intraday)
170.33M - Beta (5Y Monthly) 1.27
- PE Ratio (TTM)
196.75 - EPS (TTM)
0.04 - Earnings Date May 2, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
14.83
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
www.infusystem.comRecent News: INFU
Performance Overview: INFU
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INFU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INFU
Valuation Measures
Market Cap
170.33M
Enterprise Value
205.00M
Trailing P/E
200.25
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.38
Price/Book (mrq)
3.26
Enterprise Value/Revenue
1.63
Enterprise Value/EBITDA
12.40
Financial Highlights
Profitability and Income Statement
Profit Margin
0.69%
Return on Assets (ttm)
2.53%
Return on Equity (ttm)
1.74%
Revenue (ttm)
125.78M
Net Income Avi to Common (ttm)
872k
Diluted EPS (ttm)
0.04
Balance Sheet and Cash Flow
Total Cash (mrq)
231k
Total Debt/Equity (mrq)
69.55%
Levered Free Cash Flow (ttm)
960.35k